Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912047062> ?p ?o ?g. }
- W2912047062 endingPage "802" @default.
- W2912047062 startingPage "794" @default.
- W2912047062 abstract "Resistant hypertension prevalence is progressively increasing, and prolonged exposure to suboptimal blood pressure control results in higher cardiovascular risk and end-organ damage. Among various antihypertensive agents, spironolactone seems the most effective choice to treat resistant hypertension once triple therapy including a diuretic fails. However success in blood pressure control is not guaranteed, adverse effects are not negligible, and no clinical tools are available to predict patient’s response. Complementary to our previous study of resistant hypertension metabolism, here we investigated urinary proteome changes with potential capacity to predict response to spironolactone. Twenty-nine resistant hypertensives were included. A prospective study was conducted and basal urine was collected before spironolactone administration. Patients were classified in responders or nonresponders in terms of blood pressure control. Protein quantitation was performed by liquid chromatography–mass spectrometry; ELISA and target mass spectrometry analysis were performed for confirmation. Among 3310 identified proteins, HP (haptoglobin) and HPR (haptoglobin-related protein) showed the most significant variations, with increased levels in nonresponders compared with responders before drug administration (variation rate, 5.98 and 7.83, respectively). Protein-coordinated responses were also evaluated by functional enrichment analysis, finding oxidative stress, chronic inflammatory response, blood coagulation, complement activation, and regulation of focal adhesions as physiopathological mechanisms in resistant hypertension. In conclusion, protein changes able to predict patients’ response to spironolactone in basal urine were here identified for the first time. These data, once further confirmed, will support clinical decisions on patients’ management while contributing to optimize the rate of control of resistant hypertensives with spironolactone." @default.
- W2912047062 created "2019-02-21" @default.
- W2912047062 creator A5011947633 @default.
- W2912047062 creator A5024703929 @default.
- W2912047062 creator A5028520416 @default.
- W2912047062 creator A5037618214 @default.
- W2912047062 creator A5040062593 @default.
- W2912047062 creator A5041365741 @default.
- W2912047062 creator A5043238618 @default.
- W2912047062 creator A5049472227 @default.
- W2912047062 creator A5052366300 @default.
- W2912047062 creator A5054029950 @default.
- W2912047062 creator A5054866810 @default.
- W2912047062 creator A5081217694 @default.
- W2912047062 creator A5087248913 @default.
- W2912047062 date "2019-04-01" @default.
- W2912047062 modified "2023-10-17" @default.
- W2912047062 title "Urine Haptoglobin and Haptoglobin-Related Protein Predict Response to Spironolactone in Patients With Resistant Hypertension" @default.
- W2912047062 cites W1797367453 @default.
- W2912047062 cites W1833953302 @default.
- W2912047062 cites W1845544526 @default.
- W2912047062 cites W1970554352 @default.
- W2912047062 cites W1976327004 @default.
- W2912047062 cites W1990518394 @default.
- W2912047062 cites W1993382349 @default.
- W2912047062 cites W2013681281 @default.
- W2912047062 cites W2018680621 @default.
- W2912047062 cites W2040758605 @default.
- W2912047062 cites W2041218928 @default.
- W2912047062 cites W2041910678 @default.
- W2912047062 cites W2056851154 @default.
- W2912047062 cites W2062256838 @default.
- W2912047062 cites W2065522670 @default.
- W2912047062 cites W2072374715 @default.
- W2912047062 cites W2079249804 @default.
- W2912047062 cites W2094229819 @default.
- W2912047062 cites W2095975665 @default.
- W2912047062 cites W2101761968 @default.
- W2912047062 cites W2122915712 @default.
- W2912047062 cites W2140628921 @default.
- W2912047062 cites W2145989311 @default.
- W2912047062 cites W2150734413 @default.
- W2912047062 cites W2155142785 @default.
- W2912047062 cites W2171976555 @default.
- W2912047062 cites W2172086404 @default.
- W2912047062 cites W2190345047 @default.
- W2912047062 cites W2245960195 @default.
- W2912047062 cites W2313102331 @default.
- W2912047062 cites W2404768398 @default.
- W2912047062 cites W2480445743 @default.
- W2912047062 cites W2506720436 @default.
- W2912047062 cites W2520222164 @default.
- W2912047062 cites W2613171575 @default.
- W2912047062 cites W2748341876 @default.
- W2912047062 cites W2751995989 @default.
- W2912047062 cites W2770837559 @default.
- W2912047062 cites W2781049860 @default.
- W2912047062 cites W2782773879 @default.
- W2912047062 cites W2796100005 @default.
- W2912047062 cites W2796868581 @default.
- W2912047062 cites W2888589263 @default.
- W2912047062 cites W2910511370 @default.
- W2912047062 doi "https://doi.org/10.1161/hypertensionaha.118.12242" @default.
- W2912047062 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30712426" @default.
- W2912047062 hasPublicationYear "2019" @default.
- W2912047062 type Work @default.
- W2912047062 sameAs 2912047062 @default.
- W2912047062 citedByCount "5" @default.
- W2912047062 countsByYear W29120470622019 @default.
- W2912047062 countsByYear W29120470622020 @default.
- W2912047062 countsByYear W29120470622021 @default.
- W2912047062 countsByYear W29120470622022 @default.
- W2912047062 crossrefType "journal-article" @default.
- W2912047062 hasAuthorship W2912047062A5011947633 @default.
- W2912047062 hasAuthorship W2912047062A5024703929 @default.
- W2912047062 hasAuthorship W2912047062A5028520416 @default.
- W2912047062 hasAuthorship W2912047062A5037618214 @default.
- W2912047062 hasAuthorship W2912047062A5040062593 @default.
- W2912047062 hasAuthorship W2912047062A5041365741 @default.
- W2912047062 hasAuthorship W2912047062A5043238618 @default.
- W2912047062 hasAuthorship W2912047062A5049472227 @default.
- W2912047062 hasAuthorship W2912047062A5052366300 @default.
- W2912047062 hasAuthorship W2912047062A5054029950 @default.
- W2912047062 hasAuthorship W2912047062A5054866810 @default.
- W2912047062 hasAuthorship W2912047062A5081217694 @default.
- W2912047062 hasAuthorship W2912047062A5087248913 @default.
- W2912047062 hasBestOaLocation W29120470621 @default.
- W2912047062 hasConcept C126322002 @default.
- W2912047062 hasConcept C134018914 @default.
- W2912047062 hasConcept C206396517 @default.
- W2912047062 hasConcept C2776379505 @default.
- W2912047062 hasConcept C2778024521 @default.
- W2912047062 hasConcept C2778198053 @default.
- W2912047062 hasConcept C2780026642 @default.
- W2912047062 hasConcept C555293320 @default.
- W2912047062 hasConcept C71924100 @default.
- W2912047062 hasConcept C84393581 @default.
- W2912047062 hasConcept C90924648 @default.